IR
Superintel
Overview
Markets
Watchlist
More
Keryx Biopharmaceuticals Inc
CUSIP: 492515951 | 5 institutional holders
Watch
Quarters
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile